Milestones ahead as the US FDA takes charge of synthetic nicotine regulation

The passage of the  $1.5tn omnibus spending bill and its rider giving the US Food and Drug Administration (FDA) authority to regulate synthetic nicotine products in the same way that tobacco products are regulated will irrevocably change the US vaping market.

Now that president Joe Biden has signed the bill into law, there are a number of major milestones to look out for over the coming months. ECigIntelligence has put together a timeline outlining the major points to look out for over the summer as the FDA brings synthetic nicotine into the PMTA process.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more


    – ECigIntelligence staff

    Author default picture


    This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization